;
Skip to main content
Home > Week in Review > Management

Chronological Index of : Management Tracks

 Current Issue
  • Advanced Cell Technology management update

    Advanced Cell Technology Inc. (OTCBB:ACTC), Marlborough, Mass. Business: Gene/Cell therapy, Cardiovascular, Ophthalmic Hired: LeRoux Jooste as SVP of business development, a newly created position, and chief commercial …

    Published on 10/27/2014
  • Advaxis management update

    Advaxis Inc. (NASDAQ:ADXS), Princeton, N.J. Business: Cancer, Infectious Hired: David Mauro as EVP and CMO, formerly executive director and section head of oncology clinical development at Merck & Co. Inc.

    Published on 10/27/2014
  • Ameritox management update

    Ameritox Ltd., Baltimore, Md. Business: Diagnostic Hired: Thomas Smith as CMO, formerly CMO of Mallinckrodt plc

    Published on 10/27/2014
  • Anaptys management update

    AnaptysBio Inc., San Diego, Calif. Business: Inflammation, Cancer, Antibodies Hired: Marco Londei as chief development officer, a newly created position, formerly therapeutic area head of immunosciences at Bristol-Myers…

    Published on 10/27/2014
  • Appistry management update

    Appistry Inc., St. Louis, Mo. Business: Bioinformatics Hired: Cornelius Boerkoel as CMO, a newly created position

    Published on 10/27/2014
  • Cubist management update

    Cubist Pharmaceuticals Inc. (NASDAQ:CBST), Lexington, Mass. Business: Infectious Transitioning: President and COO Robert Perez to CEO, effective Jan. 1, 2015; he succeeds Michael Bonney who will become chairman; Bonney …

    Published on 10/27/2014
  • CytRx board of directors update

    CytRx Corp. (NASDAQ:CYTR), Los Angeles, Calif. Business: Cancer Appointed: Steven Kriegsman, president, CEO and a director, as chairman; he succeeds Max Link, who passed away

    Published on 10/27/2014
  • Epic Sciences management update

    Epic Sciences Inc., La Jolla, Calif. Business: Diagnostic Hired: Michael Giske as chief information officer, formerly director of IT strategy and architecture at Oracle Corp.

    Published on 10/27/2014
  • Forendo Pharma board of directors update

    Forendo Pharma Oy, Turku, Finland Business: Genitourinary, Endocrine/Metabolic Appointed: Hakan Goker, an investment director at MS Ventures; and Anja Konig, managing director at Novartis Venture Fund

    Published on 10/27/2014
  • Galapagos management update

    Galapagos N.V. (Euronext:GLPG; Pink:GLPYY), Mechelen, Belgium Business: Autoimmune, Musculoskeletal, Functional genomics Hired: Bart Filius as CFO, effective Dec. 1, formerly VP and CEO of Sanofi's Sanofi Europe …

    Published on 10/27/2014
  • Gruenenthal management update

    Gruenenthal Group, Aachen, Germany Business: Neurology Hired: Sascha Becker as CFO, effective 1Q15, formerly CFO of the Merck Serono S.A. biopharmaceutical division of Merck KGaA; he succeeds Stefan Genten

    Published on 10/27/2014
  • Incyte management update

    Incyte Corp. (NASDAQ:INCY), Wilmington, Del. Business: Cancer, Autoimmune, Hematology Hired: David Gryska as EVP and CFO, effective Oct. 31, formerly COO of Myrexis Inc.; he succeeds David Hastings

    Published on 10/27/2014
  • Ipsen management update

    Ipsen Group (Euronext:IPN; Pink:IPSEY), Boulogne-Billancourt, France Business: Cancer, Endocrine/Metabolic, Neurology Hired: Aymeric Le Chatelier as EVP and CFO, effective Nov. 3

    Published on 10/27/2014
  • Karus management update

    Karus Therapeutics Ltd., Chilworth, U.K. Business: Autoimmune, Caner Hired: Peter Finan as head of biology, formerly VP and global head of respiratory disease at Novartis AG; and Simon Roitt as head of clinical …

    Published on 10/27/2014
  • Luminex management update

    Luminex Corp. (NASDAQ:LMNX), Austin, Texas Business: Diagnostic, Supply/Service Retired: Patrick Balthrop as president, CEO and a director; he is succeeded by Nachum Shamir, formerly president and CEO of Given Imaging …

    Published on 10/27/2014
  • Melbourne Laboratories management update

    Melbourne Laboratories LLC, Mountain View, Calif. Business: Pharmaceuticals Hired: Ken Greathouse as CEO; Robert Pollock as president and CSO; and Brian Smith as COO

    Published on 10/27/2014
  • Navidea management update

    Navidea Biopharmaceuticals Inc. (NYSE-M:NAVB), Dublin, Ohio Business: Diagnostic Hired: Rick Gonzalez as CEO, formerly VP of global operations at Spectrum Pharmaceuticals Inc.; he succeeds interim CEO Michael Goldberg

    Published on 10/27/2014
  • Otonomy management update

    Otonomy Inc. (NASDAQ:OTIC), San Diego, Calif. Business: Other, Drug delivery, Infectious Hired: Anthony Yost as chief commercial officer, formerly chief commercial officer of the Prometheus Laboratories Inc. unit of …

    Published on 10/27/2014
  • Regado Biosciences management update

    Regado Biosciences Inc. (NASDAQ:RGDO), Basking Ridge, N.J. Business: Cardiovascular Transitioned: Michael Metzger to CEO and a director from president and COO; he succeeds David Mazzo, who resigned

    Published on 10/27/2014
  • Revalesio management update

    Revalesio Corp., Tacoma, Wash. Business: Inflammation, Neurology, Cardiovascular Hired: Bert van den Bergh as president, formerly president of neuroscience products, president of European operations, and general manager…

    Published on 10/27/2014
  • Shire management update

    Shire plc (LSE:SHP; NASDAQ:SHPG), Dublin, Ireland Business: Neurology, Gastrointestinal, Endocrine/Metabolic Departing: James Bowling as interim CFO, effective 1Q15, to become CFO of Severn Trent plc

    Published on 10/27/2014
  • Sucampo management update

    Sucampo Pharmaceuticals Inc. (NASDAQ:SCMP), Bethesda, Md. Business: Gastrointestinal, Ophthalmic, Neurology Hired: Matthias Alder as EVP of business development and licensing, formerly EVP of corporate development and …

    Published on 10/27/2014
  • Synlogic management update

    Synlogic Inc., Cambridge, Mass. Business: Gastrointestinal Hired: Paul Miller as CSO, formerly VP of infection biology research at AstraZeneca plc; and Alison Silva as COO, formerly COO of S.L.A. Pharma AG

    Published on 10/27/2014
  • Therapix management update

    Therapix Biosciences Ltd. (Tel Aviv:TRPX; OTCQB:THXBY), Ness Ziona, Israel Business: Neurology, Autoimmune, Inflammation Hired: Jan Turek as CEO

    Published on 10/27/2014
  • Theravance management update

    Theravance Inc. (NASDAQ:THRX), South San Francisco, Calif. Business: Infectious. Gastrointestinal, Pulmonary Hired: Eric d'Esparbes as SVP and CFO, formerly CFO of Joule Unlimited Inc.; he succeeds Michael Aguiar

    Published on 10/27/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993